April 16, 2024
(press release)
–
Evonik is presenting its latest innovations at the leading cosmetic tradeshow in-cosmetics global in Paris, 16-18 April, 2024. At this year’s show, Evonik will focus on its growing portfolio of biosolutions, including its sustainable biosurfactants and biotech actives. By expanding its range of biosolutions, Evonik is leveraging its biotechnology platform, which is part of the company’s life sciences division Nutrition & Care. The division uses biotechnology to create high-value system solutions that are driving Evonik’s transformation to become the preferred specialties partner to the cosmetics and personal care industry. “Our vision is driven by sustainability, inspired by innovation and defined by collaboration! With so many new innovations to present at this year’s show, I can truly say that we are living this vision,” said Johann-Caspar Gammelin, president of Evonik’s Nutrition & Care division. “We are committed to becoming the leading sustainable specialties partner to our industries, and we are energetically pursuing this goal through acquisitions, innovation, sustainability and service. I invite our customers and prospects to come and talk to us and find out how we can work together!” said Yann d'Hervé, head of Evonik's Care Solutions business line. Earlier this year, Evonik manufactured the first products from its new biosurfactants plant – the first in the world to produce rhamnolipids on an industrial scale. The official opening of this plant is planned for May 2024. Evonik’s biosurfactants are recognized for their exceptional sustainability credentials without compromising on performance and are already marketed in the personal care industry. Evonik’s biotech actives are also being featured prominently during the show. This year, Evonik is celebrating the 30th anniversary of the technology that enabled the production of pure, skin-identical ceramides. Three decades on, Evonik continues to innovate ceramides and sphingolipids, their biological pathways, and versatile claims. Following a series of successful acquisitions, Evonik is bringing together its expertise in a new business segment, Botanicals & Natural Actives. The new segment will enable the company to better meet the growing demand for botanical extracts and claim-substantiated natural actives. The company’s actives and cosmetic ingredients business is supported by the newly established Evonik Skin Institute, which provides customers with enhanced support for claim substantiated cosmetics. Evonik’s key innovation highlights at in-cosmetics global 2024 include: Detailed information on the above innovations is available at the Evonik Booth 1K30. During the show, Evonik is hosting a series of Customer Seminars on personalized beauty such as developing a cosmetic product, fluid skin care products, lamellar liquid crystal emulsions and more. Evonik is also presenting a Technical Seminar on glycolipid biosurfactants and giving a talk on the ECOHANCE® program in the Sustainability Zone. Further Information Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15.3 billion and an operating profit (adjusted EBITDA) of €1.66 billion in 2023. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. More than 33,000 employees work together for a common purpose: We want to improve life today and tomorrow. The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.61 billion in 2023 with more than 5,600 employees. In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
